PFDSELECT MEDICAL RECEIVABLES 1017, LLC files Form D
Sold rose to $NaN (+$20.9M, +97 investors) in 264 days since the previous filing.
Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
| Filed | Form | Sold | Investors | Change |
|---|---|---|---|---|
| 2026-01-23 | D | $0 | 0 | |
| 2026-10-14 | D/A | $20.9M | 97 | +$20.9M |
| 2026-10-14 | D/A | $0 | 97 | −$20.9M |
Amount sold and investor count as restated on each of the issuer's Form D filings. A rise since the previous filing is capital closed in between.
Earlier and related filings by the same issuer and sponsor.
Sold rose to $NaN (+$20.9M, +97 investors) in 264 days since the previous filing.
Sold rose to $NaN (+$5.7M, +19 investors) in 650 days since the previous filing.
Sold rose to $NaN (+$21.2M, +100 investors) in 387 days since the previous filing.
Sold rose to $NaN (+$35.7M, +153 investors) in 550 days since the previous filing.
Sold rose to $NaN (+$2.3M) in 143 days since the previous filing.
| Gary L. Ermoian | Executive Officer, Director |
| Robert E Pryke | Executive Officer |
| Eric Hansen | Executive Officer |
[email protected] · observed Work emails for the people on the filing, where the firm publishes or patterns them, labelled by confidence — subscribers
Signed by Robert E. Pryke, Vice President,PFD Capital Partners, Inc.,a NV corp.,Manager.
Relevant to: B2B software & services sales.
The issuer's phone number and address from the filing are shown to subscribers. See plans.